Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1750000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 20th Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
1,750,000 new shares (from the exercise of 17,500 stock acquisition rights)
発行済株式総数
Exercise ratio subject to the exercise restriction: 0.66% (1,750,000 shares delivered across all series / 264,729,198 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price during the subject month was ¥24.00–¥26.60 per share. Details of the adjustment clause and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
The total number issued cannot be calculated beyond the range ascertainable from the statement that 17,500 rights represented 2.97% of the total number issued, and the specific total number issued is not disclosed. The unexercised balance was 446,999 rights as of the end of the preceding month and 429,499 rights as of the current date.
Procedures under the Corporate Code of Conduct
Regarding the status of the exercise restriction, the filing describes compliance with the exercise deadline pursuant to Article 434 of the Listing Regulations.
Most recent equity financing
Timing 23 December 2025 / Type Issuance of the 20th Series Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 20th Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 1,750,000 new shares (from the exercise of 17,500 stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 0.66% (1,750,000 shares delivered across all series / 264,729,198 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 279,917,319 shares (as of the end of the month preceding the subject period) → Not disclosed |
| Exercise price | The exercise price during the subject month was ¥24.00–¥26.60 per share. Details of the adjustment clause and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | The total number issued cannot be calculated beyond the range ascertainable from the statement that 17,500 rights represented 2.97% of the total number issued, and the specific total number issued is not disclosed. The unexercised balance was 446,999 rights as of the end of the preceding month and 429,499 rights as of the current date. |
| Procedures under the Corporate Code of Conduct | Regarding the status of the exercise restriction, the filing describes compliance with the exercise deadline pursuant to Article 434 of the Listing Regulations. |
| Most recent equity financing | Timing 23 December 2025 / Type Issuance of the 20th Series Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on monthly exercise status, and the company has provided no explanation of the reason for the exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.